MedTrace Logo

Peak Cough Flow and Cough Clearance in Patients With Muscular Dystrophy

NCT02034305 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2024-02-05

No results posted yet for this study

Summary

This study is to determine whether physiologic measures (peak cough flow, measures of respiratory muscle strength including MIP, MEP ,SNIP, and spirometry) can predict spontaneous cough clearance (as measured by a nuclear medicine study) in children with neuromuscular disease. It will also determine whether airway clearance is augmented by high frequency chest wall oscillation.

Conditions

Sponsors & Collaborators

  • Respirtech, Inc.

    collaborator INDUSTRY

  • University of Pittsburgh

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2021-01-01
Completion
2021-01-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02034305 on ClinicalTrials.gov